Given that Cryosite manages - and stores bio samples for - 100s of clinical trials, it may be useful to start a thread reporting on developments in the $1b+Australian clinical trials space.
Today, $BCT/Bluechiip MD Andrew McLellan posted an 18pp Investor Presentation.
The document includes a table revealing the Planet Innovation-backed group has sold some 4000 MEMS bio sample readers in Australia.
The readers are used for tracking bio samples in the cord blood, IVF, stem cell and other sectors.
BCT claims there are >2b samples stored world-wide and that annual growth is ~ 15%, ie >300m samples annually.
CTE Price at posting:
4.4¢ Sentiment: Hold Disclosure: Held
